GlassScriptPhysician profile
Ayesha Yahya
NPI 1780035923
$16,888.88
in general payments reported to CMS, 2019-2025
20 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $681 · 2021: $2,423 · 2022: $2,006 · 2023: $2,533 · 2024: $5,651 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,591 · Food and Beverage: $4,100 · Consulting Fee: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,591.35 |
| Food and Beverage | $4,099.95 |
| Consulting Fee | $265.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,061.04 | 2019-2025 | Infinity, Inbone, Infinity Adaptis |
| Zimmer Biomet Holdings, INC. | $3,290.55 | 2019-2024 | Rosa |
| Smith+Nephew, INC. | $2,908.53 | 2021-2025 | Na, Taylor Spatial Frame, Evos |
| Paragon 28, INC. | $1,389.27 | 2021-2024 | Portfolio, Trauma |
| Arthrex, INC. | $1,346.82 | 2022-2025 | |
| Legacy Ortho LLC | $1,318.57 | 2024-2025 | |
| Next Science LLC | $265.53 | 2024 | Xperience, Blastx, Surgx |
| Si-Bone, INC. | $250.02 | 2019-2022 | |
| Cerapedics INC. | $163.31 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Integra Lifesciences Corporation | $147.59 | 2022 | |
| Endo Pharmaceuticals INC. | $138.38 | 2021-2022 | |
| Depuy Synthes Sales INC. | $128.18 | 2019-2021 | |
| Davol INC. | $123.95 | 2022 | |
| Globus Medical, INC. | $119.77 | 2019 | |
| Restor3d, INC. | $76.05 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $60.65 | 2025 | Inceptiv |
| Medical Device Business Services, INC. | $37.86 | 2019 | |
| Orthofix Medical, INC. | $28.66 | 2025 | Accelstim |
| Abbott Laboratories | $20.59 | 2025 | Proclaim |
| Kairos Surgical INC | $13.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Yahya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.